Patent ID: 7482137
Filing Date: 2009-01-27
Classification: A61P,C07H,C12N,C12P

Abstract:
1. A hybrid glycosylated product which comprises: (a) at least one rhamnose or substituted rhamnose sugar linked to an erythronolide or an erythromycin either at the 3 position or 5 position or at both the 3 and 5 positions of said erythronolide or erythromycin, wherein the hybrid glycosylation product is other than 3-rhamnosyl-5-desosaminyl-erythronolide B, 3-rhamnosyl-6-deoxyerythromycin B, 3-rhamnosyl-erythronolide B, and 3-rhamnosyl-6-deoxyerythronolide B; (b) at least one mycarose or substituted mycarose sugar linked to an erythronolide or an erythromycin either at the 5 position or at both the 3 and 5 positions of said erythronolide or erythromycin; (c) at least one mycaminose or substituted mycaminose sugar linked to an erythronolide or an erythromycin either at the 3 position or at both the 3 and 5 positions of said erythronolide or erythromycin; or combinations of (a), (b) and (c) sugar substituents on an erythronolide or erythromycin.